Epion Therapeutics</a> (Copy)
2 known investors
Find your way into Epion Therapeutics</a> (Copy)
Sign up to see every warm intro you have to Epion Therapeutics</a> (Copy)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Epion Therapeutics</a> (Copy) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium. The company aims to bring early intervention treatment to patients globally.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Epion Therapeutics</a> (Copy) do?
- Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium. The company aims to bring early intervention treatment to patients globally.
- Who are Epion Therapeutics</a> (Copy)'s investors?
- Epion Therapeutics</a> (Copy)'s investors include 7G BioVentures, New World Angels.




